Related Funds
Fund Name | Location |
Accelerated Technologies Partners | New York, New York, United States |
Aquiline Technology Growth | New York, New York, United States |
CareerOne | Australia, New South Wales, Sydney |
Foley Ventures | Milwaukee, United States, Wisconsin |
Guotai Venture Capital | China, Jiangsu, Nantong |
Insight Technology Capital Partners | - |
ITUARI Teknokent | - |
La Nevera Roja.com | Community of Madrid, Madrid, Spain |
Leonardo Venture | Baden-Wurttemberg, Germany, Mannheim |
LITTLEROCK | Düsseldorf, Germany, Nordrhein-Westfalen |
Rongxi Venture | China, Jinshan District |
South Suez Capital | Grand Baie, Mauritius, Riviere du Rempart |
Stingray | Canada, Montréal, Quebec |
Tab The Momentum | Seoul, Seoul-t'ukpyolsi, South Korea |
Techweek | Chicago, Illinois, United States |
Uber Alumni Syndicate | - |
Xalisco Ventures | Pennsylvania, Pittsburgh, United States |
Xinjiang Yuesheng Guquan Touzi Youxian Gongsi | China, Ürümqi, Xinjiang |
Zongheng Tianxia | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Halda Therapeutics | $126M | 12 Aug 2024 | Branford, Connecticut, United States | ||
MBX Biosciences | $63M | 05 Aug 2024 | Indiana, United States | ||
Jade Biosciences | $80M | 01 Aug 2024 | Waltham, Massachusetts, United States | ||
Frontier Medicines | $20M | 25 Jun 2024 | San Francisco, California, United States | ||
TORL BioTherapeutics | $158M | 10 Apr 2024 | Los Angeles, California, United States | ||
Avenzo Therapeutics | $150M | 26 Mar 2024 | San Diego, California, United States | ||
Tubulis | $151M | 14 Mar 2024 | Munich, Bavaria, Germany | ||
LB Pharmaceuticals | $75M | 24 Jan 2024 | New York, New York, United States | ||
Mariana Oncology | $175M | 07 Sep 2023 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Halda Therapeutics | $126M | 12 Aug 2024 | Branford, Connecticut, United States | ||
MBX Biosciences | $63M | 05 Aug 2024 | Indiana, United States | ||
Jade Biosciences | $80M | 01 Aug 2024 | Waltham, Massachusetts, United States | ||
Frontier Medicines | $20M | 25 Jun 2024 | San Francisco, California, United States | ||
TORL BioTherapeutics | $158M | 10 Apr 2024 | Los Angeles, California, United States | ||
Avenzo Therapeutics | $150M | 26 Mar 2024 | San Diego, California, United States | ||
Tubulis | $151M | 14 Mar 2024 | Munich, Bavaria, Germany | ||
LB Pharmaceuticals | $75M | 24 Jan 2024 | New York, New York, United States | ||
Mariana Oncology | $175M | 07 Sep 2023 | - |